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Abstract
Introduction: Mesenchymal stem cells are adult stem cells capable of self-renewal and multilineage differentiation
(Schweizer et al., 2015). Adipose derived stem cells have been used in breast reconstruction following surgical
intervention in breast cancer patients. MicroRNAs(miRNA) have been linked to gene regulation essential in
oncogenic, and tumour suppression as well as cell signalling pathways in BC.
Aim: To research the hypothesis of ADSCs and their therapeutic properties in BC patients.
Methods: Proliferation assays were carried out to demonstrate how ADSC conditioned media influenced BC cell
lines MDA-MB-231, SKBR3, and T47D. The expression of six miRNAs (miR-21, miR-133, miR-222, miR-146,
miR-221, and miR-A) and three cytokines (TGF-β, RANTES, TNF- α) was determined using a variety of
functional assays. Statistical analysis was performed using Minitab 20.1.0.
Findings: Upregulation of miRNA expression all miR-21 co-culture samples, miR-222 T47D co-culture, and both
miR-146, and miR-221’s SKBR3 BC co-culture cell line. All co-culture cells within miR-133 expression displayed
downregulation of high significance, and co-culture cells lines MDA-MB-231 and SKBR3 expressing miR-222.
Down-regulation was observed in all cytokine samples (p<0.001) of BC cell co-cultures, apart from RANTES
concentration within SKBR3 (p<0.05). This research demonstrated how ADSCs have properties as a double-edged
sword by providing insight upon ADSCs influence on BC malignancy properties. Which in future could be a
target for novel treatment therapies, thus giving patients a better prognosis and survival rate by providing a
personalised molecular approach of treatment.
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1. Introduction
Breast Cancer (BC) is the most diagnosed form of cancer for women worldwide. With over
3,600 women diagnosed annually in Ireland alone, this disease proceeds to be the primary cause
of death in women worldwide (Alam et al., 2022). The most common treatment option for BC
patients is surgical intervention, although often successful, these methods mutilate the breast
tissue and frequently require fat engraftment (Schweizer et al., 2015; Scioli et al., 2019).
Mesenchymal stem cells (MSCs) are multipotent adult stem cells which are capable of selfrenewal and multilineage differentiation in vitro. Sources of MSC include bone marrow, adipose
tissue, umbilical cord blood and tissue, or amniotic fluid, and potentially, although less frequent,
dental pulp and peripheral blood. Each source can differentiate into various lineages, as shown
in Figure 1. Bone marrow stem cells (BMSCs) are the gold standard source of stem cells, but
more recently adipose derived stem cells (ADSCs), isolated from white adipose tissue (WAT)
are shown to have many benefits. ADSCs extraction is much less invasive procedure, provides
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a much higher yield of stem cells by 1000-fold, requiring less time, consumables, and expense
when compared to high risk, invasive bone marrow extraction (Berebichez-Fridman & MonteroOlvera, 2018; Wang et al., 2020).

Figure 1: MSC sources and differentiation schematic (Cunningham et al. (2022).
Legislation and Ethics of Stem Cell Research
Challenges within stem cell research include both the scientific challenges, as well as ethical
and regulatory confronts. Research on adult stem cells is legal and currently being conducted in
several locations in Ireland, even though there is no specific legislation toward its research in
Ireland (European Commission, 2013). The legal situation regarding embryonic stem cell
research is less well defined, which has urged the drive to resource alternative stem cell sources
with less ethical implications. ADSCs have emerged as a promising alternative stem cell source
and have served as useful models in researching various biological interactions, like microRNA
(miRNA) dysregulation in several diseases and disorders, e.g., obesity, diabetes, and breast
cancer (Abente et al., 2016; S. Li et al., 2020). The concern of using ADSCs is their potential
to influence the progression of the BC tumour microenvironment at the site of surgical
intervention in BC patients, who are undergoing breast reconstruction via adipose tissue (Zocchi
et al., 2019). Research of reliable scientific sources debates ethical concerns of whether ADSC
application is beneficiary or destructive (Si et al. 2019).
This research will contribute to the question of how ADSCs interact with BC through miRNA
mediated communication.
ADSCs: The double-edged sword in BC therapeutics
ADSC-based therapies exert their regenerative and therapeutic properties by releasing
exosomes, secreted by MSCs into their extracellular matrix (e.g. conditioned media (CM))
(Singh et al., 2021). Cell-free therapies have been developed that exploit the therapeutic action
of ADSC-exosomes via ADSC-CM (Cai et al., 2020). Exosomes aid the transfer of molecules
like cytokines, genes and miRNAs from one cell to another (Maqsood et al., 2020). Evidence
has suggested that these extracellular vesicles can alter gene expression and function in recipient
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cells, particularly when the extracellular vesicle is acting as a carrier of RNA from one cell to
another (O’Brien et al., 2020).
ADSC-based therapies in the treatment of diseases like BC has been described as a double edged
sword encompassing both therapeutic and potential cancer enhancing effects (Lee and Hong,
2017). ADSCs secrete many growth factors in vitro including TGF-β, which participate in
increased collagen and extracellular matrix deposition necessary for tissue repair (Li et al.,
2020). Schweizer et al. (2015) observed the benefit of ADSC incorporation in fat engraftment
by the induction of endothelial cell proliferation, retaining volume and shape of the fat
engraftment whilst reducing scarring effects upon the tissue (Scioli et al., 2019).
On the other hand, research has presented that the interaction between ADSCs and the BC
tumour microenvironment can promote cancer progression and invasiveness, by stimulating
ADSCs to undergo epithelial to mesenchymal transition (EMT) (Wu et al., 2019). Therefore,
the use of ADSCs for tissue reconstruction in BC may potentially promote cancer metastasis,
where residual cancer cells at the site of reconstruction may be stimulated by the presence of
ADSCs to proliferate, or in contrast, transplanted ADSCs may be stimulated to become cancer
cells (Scioli et al., 2019). ADSC-free therapies in BC treatment have been observed to supress
BC migration and proliferation in vitro, with some authors observing the contrary. S. Li et al.
(2020) identified a novel antitumour ADSC subtype, that when loaded with an antitumour
miRNA was shown to be a promising therapeutic approach in BC treatment. In contrast, Wu et
al. (2019) reported that non-contact co-culture of human ADSCs and the BC cell line MCF7
increased MCF7 migration and invasion potential by altering the expression of certain
molecules involved in EMT. The interaction of ADSCs and the BC microenvironment, cancer
initiation, and stem cell-initiated tumour growth is important in advancing ADSC-based BC
therapies, and must be clarified (Fang et al., 2021; Schweizer et al., 2015). The hypothesis of
this study is to establish miRNAs as key mediators in ADSC-BC interaction.
ADSC signaling via miRNAs
While the understanding of the interaction between ADSCs and the BC microenvironment is
constantly developing as new research emerges, authors have suggested that an important factor
in the communication mechanism of the BC microenvironment could be due to the presence of
miRNAs (Qattan, 2020). MiRNAs regulate cancer cell proliferation, apoptosis, differentiation,
and metastasis, and in cases with aberrant expression, and oncogenic dysregulation can
implicate cellular signalling, thus stimulating cancer (Kaboli et al., 2015). MiRNAs have been
shown to regulate cytokines following their transcription (Lischka et al., 2021). Authors have
highlighted that some miRNAs may play a role in the regulation of the pro-inflammatory
cytokine activity in cancer-related inflammation, however, cytokines 1L-1β, TNF-α and IFN-γ
have been demonstrated to control miR-21, miR-34a and miR-146a expression levels
(Chakraborty et al., 2020). Exosomal miRNAs have been demonstrated to act as oncogenic and
tumour suppressor molecules in breast cancer (Wong, Abu Jalboush and Lo, 2020). Indirectly
co-culturing breast cancer cells with ADSC-CM is an important step in understanding the
interaction between ADSC and BC in terms of current therapies (i.e. tissue reconstruction), and
also in terms of novel ADSC-based therapies where developing the understanding of how
ADSC-CM (containing exosomes, miRNAs and cytokines) interacts with BC, potentially
leading to the identification of novel drug delivery mechanisms or therapeutic targets to treat
this prevalent disease (Hong et al., 2019; Asgarpour et al., 2020; Liu et al., 2022).
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This research will investigate the influence of ADSCs upon the BC tumour microenvironment
with the aim of identifying novel targets for miRNA-based therapies.

2. Materials and Methods
BC Cell Line Selection
To understand the interaction between ADSCs and BC, three ADSC-BC cell line co-cultures
were studied; ADSC-MDA-MB-231, ADSC-T47D and ADSC-SKBR3. These BC cell lines
were chosen due to their suitability as BC cell models and due to their characteristics, as this
study aimed to investigate the interaction of ADSC and BC as broadly as possible to account
for varying degrees of cancerous properties (e.g., aggressiveness, invasiveness, and
proliferation). To be inclusive of this, it was desired to include a basal, triple negative subtype
(MDA-MB-231), a luminal, HER2+ subtype (SKBR3) and a luminal A, HER- subtype (T47D).
Table 1: BC Cell Lines considered.
PR

HER2+

In culture

Basal B, Claudin low

-

-

Stellate

T47D

Luminal A

+

+

-

Mass

SKBR3

Luminal, Her2+

-

-

+

Grape-like

BCC Line

Classification

MDA-MB231

ER

(Schweizer et al. 2015; Lee et al., 2017)
ADSC isolation
Human adipose tissue was obtained from healthy volunteers with informed patient consent and
ethical approval. ADSCs were isolated via collagenase digestion. The isolated ADSCs were
then cultured at 37°C and 5% CO2 for 2-3 days with supplemented high glucose Dulbecco’s
Modified Eagle Media (DMEM) (10% FBS, 1% Penicillin/Streptomycin and 1% L-Glutamine).
Upon confluency, cells were passaged and cultured with fresh supplemented media for a further
48 hours. After 48 hours, the ADSC-CM was collected and stored at -80°C for use in the ADSCbreast cancer cell co-cultures.
Indirect ADSC-BC co-culture
Breast cancer cell lines, MDA-MB-231, SKBR3 and T47D cells were seeded at 8 x 104
cells/well in separate 96 well plates and incubated for 24 hours. Following this 24-hour
incubation, the BC cell lines were incubated with ADSC-CM for 24, 48, 72 hours and 7 days.
After these incubation periods, culture media was collected and stored at -80°C for cytokine
secretion analysis. The adhered cells were harvested and pelleted for miRNA isolation and
expression analysis.
Proliferation Analysis
The effect of co-culture with ADSC-CM on MDA-MB-231, SKBR3, and T47D proliferation
compared to BC cell lines cultured alone over a 24-hour period was determined by MTT assay.
Absorbance readings at 540nmwere obtained and processed to establish the percentage
proliferation.
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Enzyme Linked Immunosorbent Assay (ELISA)
After 24, 48, 72 hours and 7-day incubation with ADSC-CM, ADSC-BC culture media was
collected to quantify TGF-β, RANTES and TNF-α secretion by ELISA (ThermoFisher) as per
manufacturer's guidelines.
RNA isolation and RT-qPCR analysis
MiRNA was extracted from control ADSCs and each ADSC-BC coculture using the mirVana™
miRNA Isolation Kit (ThermoFisher) as per the manufacturer’s instructions. Isolated miRNA
was converted to complementary DNA (cDNA) using Reverse transcription polymerase chain
reaction (RT-PCR). The cDNA templates for each control (endogenous and negative) and each
sample were primed with TaqMan primers (ThermoFisher), exposed to target probes (miR-21,
miR-133, miR-222, miR146, miR-221 and miR-883), quantified by RT-qPCR and reported as
raw Cycle Threshold (CT) values proportional to target miRNA expression levels. These
TaqMan primers are within the current Sanger database to deliver comprehensive analysis with
up-to-date annotation.
Data Analysis
The raw CT data obtained from RT-qPCR (miRNA analysis) and the absorbance data from
ELISA (cytokine analysis) were processed using Excel. The RT-qPCR data was interpreted and
processed into Log10 values representing the relative expression of the target miRNAs. The
absorbance values for the ELISA plates were processed in Excel to achieve the cytokine
concentrations (ng/ml). The Log10 values (relative miRNA expression levels) and cytokine
concentrations (ng/ml) were statistically analysed using Minitab 21.1.0 to determine if there
were statistically significant differences in target miRNA expression across the control and test
cohorts. In Minitab, boxplots were generated to graphically represent target miRNA expression
across the ADSC control and each ADSC-BC cell co-culture (ADSC-MDA-MB-231, ADSCSKBR3s and ADSC-T47Ds). Boxplots were also created to depict cytokine secretion levels in
the control and ADSC-BC cell line cocultures. Two sample t-tests were executed to obtain pvalues which were indicative of the level of significance in target miRNA expression (miR-21,
miR-133, miR-222, miR-146, miR-221 and miR-883) across control ADSC and ADSC-BC cell
line cocultures (ADSC-MDA-MB-231, ADSC-SKBR3 and ADSC-T47D). The levels of
significances were no significance (p > 0.05), significant (p< 0.05*) and highly significant (p<
0.01** and p< 0.001***).

3. Results
BC Cell Line Selection
To understand the interaction between ADSCs and BC, three ADSC-BC cell line co-cultures
were studied; ADSC-MDA-MB-231, ADSC-T47D and ADSC-SKBR3. These BC cell lines
were chosen due to their suitability as BC cell models and due to their characteristics, as this
study aimed to investigate the interaction of ADSC and BC as broadly as possible to account
for varying degrees of cancerous properties (e.g., aggressiveness, invasiveness, and
proliferation). To be inclusive of this, it was desired to include a basal, triple negative subtype
(MDA-MB-231), a luminal, HER2+ subtype (SKBR3) and a luminal A, HER- subtype (T47D).
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Table 1: BC Cell Lines considered.
PR

HER2+

In culture

Basal B, Claudin low

-

-

Stellate

T47D

Luminal A

+

+

-

Mass

SKBR3

Luminal, Her2+

-

-

+

Grape-like

BCC Line

Classification

MDA-MB231

ER

(Schweizer et al. 2015; Lee et al., 2017)
ADSC isolation
Human adipose tissue was obtained from healthy volunteers with informed patient consent and
ethical approval. ADSCs were isolated via collagenase digestion. The isolated ADSCs were
then cultured at 37°C and 5% CO2 for 2-3 days with supplemented high glucose Dulbecco’s
Modified Eagle Media (DMEM) (10% FBS, 1% Penicillin/Streptomycin and 1% L-Glutamine).
Upon confluency, cells were passaged and cultured with fresh supplemented media for a further
48 hours. After 48 hours, the ADSC-CM was collected and stored at -80°C for use in the ADSCbreast cancer cell co-cultures.
Indirect ADSC-BC co-culture
Breast cancer cell lines, MDA-MB-231, SKBR3 and T47D cells were seeded at 8 x 104
cells/well in separate 96 well plates and incubated for 24 hours. Following this 24-hour
incubation, the BC cell lines were incubated with ADSC-CM for 24, 48, 72 hours and 7 days.
After these incubation periods, culture media was collected and stored at -80°C for cytokine
secretion analysis. The adhered cells were harvested and pelleted for miRNA isolation and
expression analysis.
Proliferation Analysis
The effect of co-culture with ADSC-CM on MDA-MB-231, SKBR3, and T47D proliferation
compared to BC cell lines cultured alone over a 24-hour period was determined by MTT assay.
Absorbance readings at 540nmwere obtained and processed to establish the percentage
proliferation.
Enzyme Linked Immunosorbent Assay (ELISA)
After 24, 48, 72 hours and 7-day incubation with ADSC-CM, ADSC-BC culture media was
collected to quantify TGF-β, RANTES and TNF-α secretion by ELISA (ThermoFisher) as per
manufacturer's guidelines.
RNA isolation and RT-qPCR analysis
MiRNA was extracted from control ADSCs and each ADSC-BC coculture using the mirVana™
miRNA Isolation Kit (ThermoFisher) as per the manufacturer’s instructions. Isolated miRNA
was converted to complementary DNA (cDNA) using Reverse transcription polymerase chain
reaction (RT-PCR). The cDNA templates for each control (endogenous and negative) and each
sample were primed with TaqMan primers (ThermoFisher), exposed to target probes (miR-21,
miR-133, miR-222, miR146, miR-221 and miR-883), quantified by RT-qPCR and reported as
raw Cycle Threshold (CT) values proportional to target miRNA expression levels. These
TaqMan primers are within the current Sanger database to deliver comprehensive analysis with
up-to-date annotation.
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Data Analysis
The raw CT data obtained from RT-qPCR (miRNA analysis) and the absorbance data from
ELISA (cytokine analysis) were processed using Excel. The RT-qPCR data was interpreted and
processed into Log10 values representing the relative expression of the target miRNAs. The
absorbance values for the ELISA plates were processed in Excel to achieve the cytokine
concentrations (ng/ml). The Log10 values (relative miRNA expression levels) and cytokine
concentrations (ng/ml) were statistically analysed using Minitab 21.1.0 to determine if there
were statistically significant differences in target miRNA expression across the control and test
cohorts. In Minitab, boxplots were generated to graphically represent target miRNA expression
across the ADSC control and each ADSC-BC cell co-culture (ADSC-MDA-MB-231, ADSCSKBR3s and ADSC-T47Ds). Boxplots were also created to depict cytokine secretion levels in
the control and ADSC-BC cell line cocultures. Two sample t-tests were executed to obtain pvalues which were indicative of the level of significance in target miRNA expression (miR-21,
miR-133, miR-222, miR-146, miR-221 and miR-883) across control ADSC and ADSC-BC cell
line cocultures (ADSC-MDA-MB-231, ADSC-SKBR3 and ADSC-T47D). The levels of
significances were no significance (p > 0.05), significant (p< 0.05*) and highly significant (p<
0.01** and p< 0.001***).

4. Discussion
This study in an extension upon previous undergraduate research, concentrating on ADSCs
effect on the BC tumour microenvironment. The findings in this paper demonstrate the
molecular individuality of the disease between different subtypes of BC; basal (MDA-MB-231)
and luminal A, HER- subtype (T47D), and luminal, HER2+ (SKBR3) (Scioli et al., 2019). This
study provides valuable insight toward the significance ADSC CM has upon the interaction with
both BC malignancy, and tumour suppressive properties in the direction of the investigation of
potential targeted therapeutic approaches in conjunction with gold standard cancer therapies
(Scioli et al., 2019).
This study explored whether ADSCs are safe within the BC microenvironment. Recent clinical
trials have shown that there is no significant difference in breast cancer recurrence rates with
the use of ADSC in therapeutics, yet a pattern is demonstrated throughout literature that ADSCs
contain both stimulatory and inhibitory effects as a double-edged sword (Scioli et al., 2019).
The proliferative activity of three BC cell lines was stimulated in the presence of ADSC CM
compared to when these BC cells were cultured alone, with the greatest proliferation observed
in the MDA-MB-231 cell lines. Many complex external factors within cell communities can
influence this, therefore, miRNA expression and cytokine pathways were analysed to
understand the underlying mechanism (Kumari & Gupta, 2021).
Cycle threshold (Ct) of target genes allowed for the selection of the endogenous control, miR16, a miRNA with the least irregularity and the greatest stability for this cohort. The results
found in this study provide information upon the ADSC-CM interaction with three BC subtypes
in comparison to normal miRNA expression in ADSCs.
MiR-21 is a commonly studied oncogene in many human malignancies (Fu et al., 2011).
Previous studies have shown that its overexpression correlates with BC proliferation,
progression and metastasis, deteriorating patient prognosis as it targets the inhibition of cell
cycle arrest, thus making for a much more severe BC phenotype (Javanmardi et al., 2017;
Najjary et al., 2020). MiR-21 expression contributes toward angiogenesis and vascularization
of endothelial cells in tissue reconstruction, a commonly discussed feature of ADSCs doubleedged sword (An et al., 2019; Schweizer et al., 2015). This research showed a significant
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increase in miR-21 expression with co-cultured MDA-MB-231, SKBR3, and T47D, supporting
documentation of oncogenic risk of ADSC CM use in BC patients.
MiR-133 has been identified as a significant tumour suppressor in BC. Its overexpression
correlates with the suppress of proliferation and colony formation, as well as increased apoptosis
of BC cells (Zhang et al., 2020.), Moreover, miR-133 has previously been linked to BC patient
survival rates, and a reduction in BC metastasis (Hesari et al., 2019) Consistently throughout
literature, the down regulation and low expression of miR-133 is associated with BC cell
proliferation. This study demonstrated a downregulated response miRNA expression,
specifically in progesterone regulated T47D subtypes, as progesterone induces miR-133
expression from endothelial and epithelial cells (Pan et al., 2017).
MiR-146 has been observed to stimulate cancer development, and was shown to promote
proliferation and invasion of BC (Chen et al., 2020; Liu et al., 2020). The results in these
findings present a significant increase in miR-146 in the SKBR3-ADSC co-culture and no
significant change in the other BC subtypes. This disputes the literature’s evidence of significant
upregulation of miR-146 in MDA-MB-231 subtype, decreases expression of epidermal growth
factor receptor (EGFR), to inhibit invasion and migration in vitro (Hurst et al., 2009). Reasoning
for this discrepancy may be due to ADSC donor variation, use of endogenous control, varying
miRNA isolation methods or normalisation of miRNA expression profiles which has previously
been observed in the literature (Pamedytyte et al., 2020).
Previous research has documented that both miR-221, and miR-222 are homologous miRNAs
whose overexpression is associated with many malignant cancer types (Fu et al. 2011). MiR221 may stimulate BC progression and metastasis (Liu, Wang, and Sun, 2019; S. Li et al., 2020),
whereas miR-222 may induce drug resistance in BC cells and potentially enhance BC
malignancy (Shen et al., 2017; Amini et al., 2018). Both miRNAs have motility properties
associated in metastatic cancer types, demonstrating a link between ADSC’s part in EMT via
paracrine signalling (Wang et al. 2020). This study found miR-221 expression significantly
upregulated in SKBR3 co-culture, indicating proliferation and metastatic properties. Whereas,
miR-222 expression in luminal A, HER- subtype T47D-ADSC co culture was of no significance.
This was refuted in the other BC subtype co-cultures MDA-MB-231 and SKBR3, where
expression of miR-222 was significantly high, indicating the suppression of oncogenic
properties. These results demonstrate the importance of individuality of disease subtypes and
the influence even homologous miRNAs have on the specifics of the disease.
MiR-883 has not yet been documented in literature demonstrating a pattern of interaction with
BC and ADSC CM. No co-culture samples had notable significance in its expression. The coculture of T47D and ADSC CM had a similar downregulated expression to ADSC CM, opposite
to the upregulated cellular response of MDA-MB-231, and SKBR3 co-culture samples.
Furthermore, this study provided insight into ADSC-CM cytokine secretions within co-cultured
BC cell lines, and their influence upon migratory factors and effects. Early studies highlight
TGF-β tumour suppression properties in BC, and recent studies conclude that TGF-β
dysregulation can promote cancer development via proliferation, apoptosis, differentiation,
EMT, and migration (Zhang et al., 2020). The TGF-β signalling pathway crosstalk’s with other
signalling pathways to regulate cellular functions (Syed 2016).
Each co-cultured BC subtypes in this study displayed a significant downregulated response in
TGF-β cytokine expression, particularly the luminal A HER- subtype, T47D, complimenting the
preliminary hypothesis that the ADSC-CM have the potential to supress this pathway in cancer
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metastasis (Wahdan-Alaswad et al., 2016). These results support previous research findings in
with T47D cell line is not sensitive to TGF-β (Syed 2016; Xu et al., 2018).
RANTES is a major chemoattractant chemokine secreted by BC cells which contributes to
tumour progression by monocyte migration, increasing BC aggression. ADSC-CM have been
documented to have a negative response to this as they promote cell motility and infiltration of
leukocytes to tumours by secreting RANTES (Gallo et al., 2018). This study demonstrated
significant up-regulation of the SKBR3 cell line and RANTES chemokine expression, a
prevalent risk in BC metastasis (Yaal-Hahoshen et al., 2006).
TNF-α is a highly expressed inflammatory cytokine protagonist in BC tumours, leading to
increased BC growth and metastasis. Literature has demonstrated contradictory qualities as it
has tumour promoting factors in progression and tumorigenesis, whereas local administration
of high doses of TNF-α has robust antiangiogenic and antitumoral effects, another example of
the double-edged sword (Horssen et al., 2006; Wu et al., 2019). TNF-α involvement in EMT
and BC progression also is a contributor toward acquired drug resistance. This study shows that
co-culture of selected BC subtypes with ADSC CM enhanced the secretion of anti-inflammatory
effects, particularly within T47D-ADSC-CM, suppressing carcinogenic properties. These
results and previous literature provide the hypothesis of using TNF-α toward cancer suppression
therapy (Cruceriu et al., 2020).
Limitations which affected this study primarily revolved around the ongoing COVID19
pandemic, because of this increased pressure was implemented upon sourcing of materials and
their viability due to extension on deliveries. This is turn had a cumulative effect of time
constraints within the laboratory, as well as not having access to equipment within the research
centre thus increasing the workload over a shortened period.
The novelness of this research also acted as a weakness, as throughout the literature ADSC
implementation in BC is discussed as a double-edged sword, contrasting in a definite hypothesis
of beneficiary or destructive effects on BC patients.

5. Conclusions
The focus of this study involved ADSC-CM interaction with the BC tumour microenvironment
by concentrating upon the impact of changes in cellular proliferation, gene expression, and
cellular communication by protein expression within co-cultured samples reflective of each BC
subtype. Results demonstrated that ADSC-CM significantly affected multiple malignant
features of BC cells in vitro, such as miRNA gene expression and proliferation. Luminal A,
HER- subtype T47D co-culture demonstrated an overall pattern on tumour suppression
throughout miRNA and cytokine expression, despite increased proliferation. Whereas there was
a large correlation between miRNAs, cytokines involved in EMT and carcinogenic properties
providing an increased oncogenic risk in BC patients.
Additionally, this research provided a crucial insight into the importance of rigorously screening
patients for premalignant or residual lesions prior to process of lipografting, with additional
stem cell-augmentation, or isolated ADSC CM in the breast or adjacent tissues, to avoid a
potential risk increase of disease.
Further investigation toward utilising miRNAs and their interaction with the BC
microenvironment as a target for novel treatment therapies may potentially facilitate the gap in
research for this prevalent disease, giving patients a better prognosis and survival rate by
providing a personalised molecular approach of treatment. Reflecting upon this study as
previous limitations are now less pronounced, this project would benefit from expanding BC
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cell line classifications to include primary as well as commercial lines, thus increasing variety
to correlate results. The introduction of compound testing to discover its effect upon miRNA
regulator targeted therapies could also enhance suppressive factors of BC in ADSC
implementation.

6. Acknowledgements
I am grateful to the Technological University of the Shannon for the opportunity to study within
their fantastic facilities, to extend my knowledge in science, amongst Ava O'Meara and Cathy
Brougham, whose expertise were invaluable in formulating the research questions and
methodology as well as providing never-ending support and guidance throughout my studies
within the lab and externally.

7. References
Abente, E. J., Subramanian, M., Ramachandran, V. and Najafi-Shoushtari, S. H. (2016)
MicroRNAs in obesity-associated disorders, Archives of Biochemistry and Biophysics, 108–
119. doi: 10.1016/j.abb.2015.09.018.
Alam, M.S., Rahaman, M.M., Sultana, A., Wang, G., and Mollah, M.N.H. (2022) Statistics and
network-based approaches to identify molecular mechanisms that drive the progression of breast
cancer, Computers in Biology and Medicine, 145. doi: 10.1016/j.compbiomed.2022.105508
Amini, S., Abak, A., Estiar, M., Montazeri, V., Abhari, A. and Sakhinia, E. (2018) Expression
analysis of microRNA-222 in breast cancer, Clinical Laboratory, 64(4), 491–496. doi:
10.7754/Clin.Lab.2017.171002.
An, Y., Zhao, J., Nie, F., Qin, Z., Xue, H., Wang, G., & Li, D. (2019) Exosomes from AdiposeDerived Stem Cells (ADSCs) Overexpressing miR-21 promote vascularization of endothelial
cells. Scientific Reports, 9(1). https://doi.org/10.1038/S41598-019-49339-Y
Asgarpour, K., Shojaei, Z., Amiri, F., Ai, J., Mahjoubin-Tehran, M., Ghasemi, F., ArefNezhad,
R., Hamblin, M. R. and Mirzaei, H. (2020) Exosomal microRNAs derived from mesenchymal
stem cells: cell-to-cell messages, Cell Communication and Signaling, 18(1), p. 149. doi:
10.1186/s12964-020-00650-6.
Berebichez-Fridman, R., & Montero-Olvera, P. R. (2018). Sources and clinical applications of
mesenchymal stem cells: state-of-the-art review. Sultan Qaboos University Medical Journal,
18(3), e264. https://doi.org/10.18295/SQUMJ.2018.18.03.002.
Cai, Y., Li, J., Jia, C., He, Y. and Deng, C. (2020) ‘Therapeutic applications of adipose cell-free
derivatives: a review’, Stem Cell Research & Therapy, 11(1). doi: 10.1186/s13287-020-018313.
Chakraborty, C., Sharma, A. R., Sharma, G. and Lee, S. S. (2020) ‘The Interplay among
miRNAs, Major Cytokines, and Cancer-Related Inflammation’, Molecular Therapy - Nucleic
Acids. Cell Press, 20, pp. 606–620. doi: 10.1016/j.omtn.2020.04.002.
Chen, J., Jiang, Q., Jiang, X.-Q., Li, D.-Q., Jiang, X.-C., Wu, X.-B. and Cao, Y.-L. (2020) MiR146a promoted breast cancer proliferation and invasion by regulating NM23-H1, The Journal
of Biochemistry, 167(1), 41–48. doi: 10.1093/jb/mvz079.
Cruceriu, D., Baldasici, O., Balacescu, O., & Berindan-Neagoe, I. (2020). The dual role of tumor
necrosis factor-alpha (TNF-α) in BC: molecular insights and therapeutic approaches. Cellular
Oncology, 43(1). https://doi.org/10.1007/S13402-019-00489-1

https://arrow.tudublin.ie/sure_j/vol4/iss1/6

10

Cunningham et al.: The interaction of Adipose Derived Stem Cells and Breast Cancer

Science Undergraduate Research Experience
Volume (XX), Issue (XX)

Author et al

European Commission (2013). Declarations of the Commission (Framework Programme)
(2013/C
373/02).
Available
at:
https://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:373:0012:0015:EN:PDF [Accessed
02 June 2022].
Fang, J., Chen, F., Liu, D., Gu, F. and Wang, Y. (2021) Adipose tissue-derived stem cells in
breast reconstruction: a brief review on biology and translation, Stem Cell Research & Therapy,
12(1), 8. doi: 10.1186/s13287-020-01955-6.
Fu, S. W., Chen, L., & Man, Y. G. (2011). MiRNA biomarkers in BC detection and
management. Journal of Cancer, 2(1), 116. https://doi.org/10.7150/JCA.2.116
Gallo, M., Frezzetti, D., Roma, C., Chicchinelli, N., Barbieri, A., Arra, C., Scognamiglio, G.,
Botti, G., De Luca, A. and Normanno, N. (2018) RANTES and IL-6 cooperate in inducing a
more aggressive phenotype in breast cancer cells, Oncotarget, 9(25), 17543–17553. doi:
10.18632/oncotarget.24784.
Hesari, A. R., Azizian, M., Darabi, H., Nesaei, A., Hosseini, S. A., Salarinia, R., Motaghi, A.
A., & Ghasemi, F. (2019). Expression of circulating miR-17, miR-25, and miR-133 in BC
patients.
Journal
of
Cellular
Biochemistry,
120(5),
7109–7114.
https://doi.org/10.1002/JCB.27984
Hong, P., Yang, H., Wu, Y., Li, K. and Tang, Z. (2019). ‘The functions and clinical application
potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review’,
Stem Cell Research & Therapy, 10(1), p. 242. doi: 10.1186/s13287-019-1358-y.
Horssen, R., Hagen, T., Eggermont, A. (2006). TNF-alpha in cancer treatment: molecular
insights, antitumor effects, and clinical utility. Oncologist, 11(4):397-408. doi:
10.1634/theoncologist.11-4-397.
Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., & Welch, D. R. (2009).
BC metastasis suppressor 1 up-regulates miR-146, which suppresses BC metastasis. Cancer
Research,
69(4),
1279–1283.
https://doi.org/10.1158/0008-5472.CAN-083559/654800/P/BREAST-CANCER-METASTASIS-SUPPRESSOR-1-UP-REGULATES
Javanmardi, S., Aghamaali, M., Abolmaali, S., Mohammadi, S., & Tamaddon, A. (2017). MiR21, an oncogenic target miRNA for cancer therapy: molecular mechanisms and recent
advancements in chemo and radio-resistance. Current Gene Therapy, 16(6), 375–389.
https://doi.org/10.2174/1566523217666170102105119.
Kaboli, P. J., Rahmat, A., Ismail, P., & Ling, K. H. (2015). MicroRNA-based therapy and BC:
A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
Pharmacological Research, 97, 104–121. https://doi.org/10.1016/J.PHRS.2015.04.015
Kumari, P., & Gupta, A. (2021). Assays to assess the proliferative behavior of cancer cells.
Protocol Handbook for Cancer Biology, 23–41. https://doi.org/10.1016/B978-0-323-900065.00002-1
Lee, H. and Hong, I. (2017) ‘Double‐edged sword of mesenchymal stem cells: Cancer‐
promoting versus therapeutic potential’, Cancer Science, 108(10), pp. 1939–1946. doi:
10.1111/cas.13334.
Li, S., Li, Q., Lü, J., Zhao, Q., Li, D., Shen, L., Wang, Z., Liu, J., Xie, D., Cho, W. C., Xu, S.
and Yu, Z. (2020) Targeted inhibition of miR-221/222 promotes cell sensitivity to cisplatin in

Published by ARROW@TU Dublin, 2022

11

SURE_J: Science Undergraduate Research Journal, Vol. 4, Iss. 1 [2022], Art. 6

Science Undergraduate Research Experience
Volume (XX), Issue (XX)

Author et al

triple-negative breast cancer MDA-MB-231 Cells, Frontiers in Genetics, 10. doi:
10.3389/fgene.2019.01278.
Li, T., Zhou, X., Wang, J., Liu, Z., Han, S., Wan, L., Sun, X. and Chen, H. (2020) Adiposederived mesenchymal stem cells and extracellular vesicles confer antitumor activity in
preclinical treatment of breast cancer, Pharmacological Research. Academic Press, 157. doi:
10.1016/j.phrs.2020.104843.
Lischka, J., Schanzer, A., Hojreh, A., Ba-Ssalamah, A., de Gier, C., Valent, I., Item, C. B.,
Greber-Platzer, S. and Zeyda, M. (2021) ‘Circulating microRNAs 34a, 122, and 192 are linked
to obesity-associated inflammation and metabolic disease in pediatric patients’, International
Journal of Obesity, 45(8), pp. 1763–1772. doi: 10.1038/s41366-021-00842-1.
Liu, T., Li, T., Zheng, Y., Xu, X., Sun, R., Zhan, S., Guo, X., Zhao, Z., Zhu, W., Feng, B., Wei,
F., Jiang, N., Wang, J., Chen, X., Fang, F., Guo, H. and Yang, R. (2022) ‘Evaluating adipose‐
derived stem cell exosomes as <scp>miRNA</scp> drug delivery systems for the treatment of
bladder cancer’, Cancer Medicine. doi: 10.1002/cam4.4745.
Liu, K., Wang, L. and Sun, E. (2019) Prognostic value of miR-221 in human malignancy:
evidence from 3041 subjects, BMC Cancer, 19(1), 867. doi: 10.1186/s12885-019-6079-1.
Liu, X., Liu, B., Li, R., Wang, F., Wang, N., Zhang, M., Bai, Y., Wu, J., Liu, L., Han, D., Li,
Z., Feng, B., Zhou, G., Wang, S., Zeng, L., Miao, J., Yao, Y., Liang, B., Huang, L., Wang, Q.
and Wu, Y. (2020) miR-146a-5p plays an oncogenic role in NSCLC via suppression of TRAF6,
Frontiers in Cell and Developmental Biology, 8. doi: 10.3389/fcell.2020.00847.
Maqsood, M., Kang, M., Wu, X., Chen, J., Teng, L. and Qiu, L. (2020) ‘Adult mesenchymal
stem cells and their exosomes: Sources, characteristics, and application in regenerative
medicine’, Life Sciences, 256. doi: 10.1016/j.lfs.2020.118002.
Najjary, S., Mohammadzadeh, R., Mokhtarzadeh, A., Mohammadi, A., Kojabad, A. B., &
Baradaran, B. (2020). Role of miR-21 as an authentic oncogene in mediating drug resistance in
BC. Gene, 738, 144453. https://doi.org/10.1016/J.GENE.2020.144453
O’Brien, K., Breyne, K., Ughetto, S., Laurent, L. C. and Breakefield, X. O. (2020) ‘RNA
delivery by extracellular vesicles in mammalian cells and its applications’, Nature Reviews
Molecular Cell Biology, 21(10), pp. 585–606. doi: 10.1038/s41580-020-0251-y.
Pamedytyte, D., Leipute, E., Zilaitiene, B., Sarauskas, V., Dauksiene, D., Dauksa, A. and
Zvirbliene, A. (2020), Different stability of miRNAs and endogenous control genes in archival
specimens of papillary thyroid carcinoma, Molecular Medicine; 26: 100. doi: 10.1186/s10020020-00218-7.

Pan, J. L., Yuan, D. Z., Zhao, Y. B., Nie, L., Lei, Y., Liu, M., Long, Y., Zhang, J. H., Blok, L.
J., Burger, C. W., & Yue, L. M. (2017). Progesterone-induced miR-133a inhibits the
proliferation of endometrial epithelial cells. Acta Physiologica (Oxford, England), 219(3), 683–
692. https://doi.org/10.1111/APHA.12762
Qattan, A. (2020) ‘Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer
Microenvironment: An Emerging Hope for a Challenging Disease’, International Journal of
Molecular Sciences, 21(23), p. 8905. doi: 10.3390/ijms21238905.
Schweizer, R., Tsuji, W., Gorantla, V. S., Marra, K. G., Rubin, J. P., & Plock, J. A. (2015). The
role of adipose-derived stem cells in BC progression and metastasis. Stem Cells International.
https://doi.org/10.1155/2015/120949

https://arrow.tudublin.ie/sure_j/vol4/iss1/6

12

Cunningham et al.: The interaction of Adipose Derived Stem Cells and Breast Cancer

Science Undergraduate Research Experience
Volume (XX), Issue (XX)

Author et al

Scioli, M. G., Storti, G., D’amico, F., Gentile, P., Kim, B. S., Cervelli, V., & Orlandi, A. (2019).
Adipose-derived stem cells in cancer progression: new perspectives and opportunities.
International Journal of Molecular Sciences, 20(13). https://doi.org/10.3390/IJMS20133296
Shen, H., Wang, D., Li, L., Yang, S., Chen, X., Zhou, S., Zhong, S., Zhao, J. and Tang, J. (2017)
MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of
PTEN/Akt/FOXO1 pathway, Gene, 596, 110–118. doi: 10.1016/j.gene.2016.10.016.
Si, Z., Wang, Xue, Sun, C., Kang, Y., Xu, J., Wang, Xidi and Hui, Y. (2019) Adipose-derived
stem cells: Sources, potency, and implications for regenerative therapies, Biomedicine &
Pharmacotherapy, 114, 108765. doi: 10.1016/j.biopha.2019.108765.
Singh, A., Raghav, A., Shiekh, P. A. and Kumar, A. (2021) ‘Transplantation of engineered
exosomes derived from bone marrow mesenchymal stromal cells ameliorate diabetic peripheral
neuropathy under electrical stimulation’, Bioactive Materials, 6(8), pp. 2231–2249. doi:
10.1016/j.bioactmat.2021.01.008.
Syed, V. (2016). TGF-β Signaling in Cancer. Journal of Cellular Biochemistry, 117(6), 1279–
1287.
Wahdan-Alaswad, R., Harrell, J. C., Fan, Z., Edgerton, S. M., Liu, B., & Thor, A. D. (2016).
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in
mesenchymal stem-like/claudin-low triple negative BC. Cell Cycle, 15(8), 1046–1059.
Wang, Y. hao, Wang, D. ri, Guo, Y. chen, Liu, J. yuan, & Pan, J. (2020). The application of
bone marrow mesenchymal stem cells and biomaterials in skeletal muscle regeneration.
Regenerative Therapy, 15, 285–294.
Wong, G. L., Abu Jalboush, S. and Lo, H.-W. (2020) ‘Exosomal MicroRNAs and
Organotropism in Breast Cancer Metastasis’, Cancers, 12(7), p. 1827. doi:
10.3390/cancers12071827.
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., and Sun, S. (2019). Cancer-associated adipocytes: key
players in breast cancer progression. Journal of Hematology & Oncology, doi: 10.1186/s13045019-0778-6.
Xu, X., Zhang, L., He, X., Zhang, P., Sun, C., Xu, X., Lu, Y., & Li, F. (2018). TGF-β plays a
vital role in triple-negative BC (TNBC) drug-resistance through regulating stemness, EMT and
apoptosis. Biochemical and Biophysical Research Communications, 502(1), 160–165.
Yaal-Hahoshen, N., Shina, S., Leider-Trejo, L., Barnea, I., Shabtai, E. L., Azenshtein, E.,
Greenberg, I., Keydar, I., & Ben-Baruch, A. (2006). The chemokine CCL5 as a potential
prognostic factor predicting disease progression in stage II BC patients. Clinical Cancer
Research, 12(15), 4474–4480.
Zhang, G., Wang, J., Zheng, R., Song, B., Huang, L., Liu, Y., Hao, Y., & Bai, X. (2020). MiR133 targets YES1 and inhibits the growth of triple-negative BC cells.
https://doi.org/10.1177/1533033820927011
Zocchi, M.L., Vindigni, V., Pagani, A., Pirro, O., Conti, G., Sbarbati, A. and Bassetto, F. (2019)
Regulatory, ethical, and technical considerations on regenerative technologies and adiposederived mesenchymal stem cells, Master Class in Plastic Surgery, 42, 531-548. doi:
10.1007/s00238-019-01571-5

Published by ARROW@TU Dublin, 2022

13

SURE_J: Science Undergraduate Research Journal, Vol. 4, Iss. 1 [2022], Art. 6

Science Undergraduate Research Experience
Volume (XX), Issue (XX)

https://arrow.tudublin.ie/sure_j/vol4/iss1/6

Author et al

14

